After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.
Teratocarcinoma-derived growth factor 1 (TDGF1), also known as CRIPTO, is expressed both in ES cells and during the early phases of embryo development. During development, CRIPTO is thought to play a role in the determination of the epiblastic cells that subsequently give rise to the mesoderm. In adults, it is reactivated in a wide range of epithelial cancers.
CRIPTO-1 antibodies are useful tools for studying embryonic development and certian cancers.
![Immunocytochemistry CRIPTO Antibody (89633) [Unconjugated] - 1](http://images.novusbio.com/fullsize/antibody/Cripto_MAB2772_Immunocytochemistry__Immunofluorescence_19953.jpg)
![Flow Cytometry CRIPTO Antibody (89633) [Unconjugated] - 1](http://images.novusbio.com/fullsize/antibody/mab2772_human-primate-cripto-1-mab-clone-89633-flow-cytometry-291202671718.jpg)
![Flow Cytometry CRIPTO Antibody (89633) [Unconjugated] - 1](http://images.novusbio.com/fullsize/antibody/mab2772_human-primate-cripto-1-mab-clone-89633-flow-cytometry-2072020141513.jpg)
![Immunocytochemistry CRIPTO Antibody [Unconjugated]](http://images.novusbio.com/fullsize/antibody/Cripto_AF1538_Immunocytochemistry__Immunofluorescence_20121.jpg)
![N/A CRIPTO [Biotin]](http://images.novusbio.com/fullsize/elisa/DATA_Cripto_DY145_ELISA_1650.jpg)
